Cargando…

Nutraceuticals in cognitive impairment and Alzheimer’s disease

Several chemical substances belonging to classes of natural dietary origin display protective properties against some age-related diseases including neurodegenerative ones, particularly Alzheimer’s disease (AD). These compounds, known as nutraceuticals, differ structurally, act therefore at differen...

Descripción completa

Detalles Bibliográficos
Autores principales: Mecocci, P., Tinarelli, C., Schulz, R. J., Polidori, M. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4066843/
https://www.ncbi.nlm.nih.gov/pubmed/25002849
http://dx.doi.org/10.3389/fphar.2014.00147
_version_ 1782322225528963072
author Mecocci, P.
Tinarelli, C.
Schulz, R. J.
Polidori, M. C.
author_facet Mecocci, P.
Tinarelli, C.
Schulz, R. J.
Polidori, M. C.
author_sort Mecocci, P.
collection PubMed
description Several chemical substances belonging to classes of natural dietary origin display protective properties against some age-related diseases including neurodegenerative ones, particularly Alzheimer’s disease (AD). These compounds, known as nutraceuticals, differ structurally, act therefore at different biochemical and metabolic levels and have shown different types of neuroprotective properties. The aim of this review is to summarize data from observational studies, clinical trials, and randomized clinical trials (RCTs) in humans on the effects of selected nutraceuticals against age-related cognitive impairment and dementia. We report results from studies on flavonoids, some vitamins and other natural substances that have been studied in AD and that might be beneficial for the maintenance of a good cognitive performance. Due to the substantial lack of high-level evidence studies there is no possibility for recommendation of nutraceuticals in dementia-related therapeutic guidelines. Nevertheless, the strong potential for their neuroprotective action warrants further studies in the field.
format Online
Article
Text
id pubmed-4066843
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-40668432014-07-07 Nutraceuticals in cognitive impairment and Alzheimer’s disease Mecocci, P. Tinarelli, C. Schulz, R. J. Polidori, M. C. Front Pharmacol Pharmacology Several chemical substances belonging to classes of natural dietary origin display protective properties against some age-related diseases including neurodegenerative ones, particularly Alzheimer’s disease (AD). These compounds, known as nutraceuticals, differ structurally, act therefore at different biochemical and metabolic levels and have shown different types of neuroprotective properties. The aim of this review is to summarize data from observational studies, clinical trials, and randomized clinical trials (RCTs) in humans on the effects of selected nutraceuticals against age-related cognitive impairment and dementia. We report results from studies on flavonoids, some vitamins and other natural substances that have been studied in AD and that might be beneficial for the maintenance of a good cognitive performance. Due to the substantial lack of high-level evidence studies there is no possibility for recommendation of nutraceuticals in dementia-related therapeutic guidelines. Nevertheless, the strong potential for their neuroprotective action warrants further studies in the field. Frontiers Media S.A. 2014-06-23 /pmc/articles/PMC4066843/ /pubmed/25002849 http://dx.doi.org/10.3389/fphar.2014.00147 Text en Copyright © 2014 Mecocci, Tinarelli, Schulz and Polidori. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Mecocci, P.
Tinarelli, C.
Schulz, R. J.
Polidori, M. C.
Nutraceuticals in cognitive impairment and Alzheimer’s disease
title Nutraceuticals in cognitive impairment and Alzheimer’s disease
title_full Nutraceuticals in cognitive impairment and Alzheimer’s disease
title_fullStr Nutraceuticals in cognitive impairment and Alzheimer’s disease
title_full_unstemmed Nutraceuticals in cognitive impairment and Alzheimer’s disease
title_short Nutraceuticals in cognitive impairment and Alzheimer’s disease
title_sort nutraceuticals in cognitive impairment and alzheimer’s disease
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4066843/
https://www.ncbi.nlm.nih.gov/pubmed/25002849
http://dx.doi.org/10.3389/fphar.2014.00147
work_keys_str_mv AT mecoccip nutraceuticalsincognitiveimpairmentandalzheimersdisease
AT tinarellic nutraceuticalsincognitiveimpairmentandalzheimersdisease
AT schulzrj nutraceuticalsincognitiveimpairmentandalzheimersdisease
AT polidorimc nutraceuticalsincognitiveimpairmentandalzheimersdisease